A presentation by Professor Paul Freemont, Head of Structural & Synthetic Biology at Imperial College London.
The global commercialisation of companies and technologies in the bioeconomy, using engineering and synthetic biology, are seeing rapid growth and advancement. However, the lack of related technical standards and metrics will likely cause major challenges. This report, drafted in collaboration with international stakeholders from academia, industry, and government, lays the groundwork for establishing open, voluntary standards for engineering biology.
Find out more: https://www.imperial.ac.uk/
This presentation was filmed at World Bio Markets on 26-27 June 2024. Find out more about the event here: https://www.worldbiomarkets.com/
